Hancock Jaffe Laboratories, Inc. Forecast, price target & analysts
$7.47
5.74%
Nasdaq, Oct 16, 04:00 pm EDT.
Closed.
Index
Industry
Hancock Jaffe Laboratories, Inc. Target price 2026 - Analyst rating & recommendation
Powered by
Hancock Jaffe Laboratories, Inc. Classifications & Recommendation
Buy
86%
Hold
14%
Hancock Jaffe Laboratories, Inc. Price Target
| Target Price | $30.60 |
| Price | $7.47 |
| Potential | |
| Number of Estimates | 3 |
| 3 Analysts have issued a price target Hancock Jaffe Laboratories, Inc. 2027 . The average Hancock Jaffe Laboratories, Inc. target price is $30.60. This is higher than the current stock price. The highest price target is , the lowest is . | |
| A rating was issued by 7 analysts: 6 Analysts recommend Hancock Jaffe Laboratories, Inc. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Hancock Jaffe Laboratories, Inc. stock has an average upside potential 2027 of . Most analysts recommend the Hancock Jaffe Laboratories, Inc. stock at Purchase. |
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028
Create a premium account to unlock analyst estimates.
Learn more
Powered by
Quarter
Annually
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| P/E | ??? |
3 Analysts have issued a Hancock Jaffe Laboratories, Inc. forecast for earnings per share. The average Hancock Jaffe Laboratories, Inc. EPS is
. This is than earnings per share in the financial year 2025. The highest EPS forecast is , the lowest is .This results in the following potential growth metrics and future valuations:
Hancock Jaffe Laboratories, Inc....
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
